Australia's largest stock trading and investment forum Australia's #1 stock forum

BIG

0.00%

$2.22 big un limited

Ann: Trading Halt, page-324

First 324 Last

Share
Profile

Follow
jlo2012

2,866 Posts.

2027

19/02/18

22:40

Post #: 31172755
Share

Originally posted by amongko ↑

Twitter post was unexpected, but in a way may be a subtle message to holders that all is taken care of.

To naysayers its simply insensitive and unprofessional in the midst of uncertainty and potential chaos.

To holders and believers of BIG they may take it as a hint of a positive outcome, that may have already eventuated and will soon be realised by all.

Sure there are things that BIG need to sort out and improve greatly on, but lessons are learnt through hardships of others or our own. BIG is a young company lead by a young CEO, they will make mistakes, no doubt. They owe it to their shareholders to be more transparent now and in the future if/when required.

Let's remember, even at his young age, Brandon is the CEO of a company that has undergone intense scrutiny and pressure over the last few weeks, would he care less about his own company to post like that? Does he think its all a joke? Would you? Unless he's got a twisted mind and enjoys seeing his shareholders in pain....I wouldn't think so.

I'm willing to give him the benefit of the doubt, and hang in there.

Still Thinking BIG

Expand

Yep, I thought the same thing Amongko when I found that tweet. I saw it as a display of confidence and yes possibly a message to share holders that everything is ok. Not fussed, business as usual.

BIG Price at posting: $2.22 Sentiment: Hold Disclosure: Held
2 Upvote

0 Great analysis

Reply

Top Stories

LRL

Labyrinth shares rocket by 219% on news of Comet Vale and Vivien gold project acquisitions

NWC

New World Resources inks complete PFS for Antler Copper Project in Arizona, USA

AI stocks: What to expect in 2024-25

CTT

Cettire shares jump on FY24 revenue growth up 80% vs pcp – but stock still badly bruised

ATH

Trial for Alterity's neurodegenerative drug ATH434 shows reduced disability